Skip to main content

Table 3 Classes of psychotropic treatment by type of bipolar disorder and nature of current mood episode

From: Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service

  Bipolar I disorder (N = 32) Bipolar II disorder (N = 81)
  Hypomania Depression Euthymia Hypomania Depression Euthymia
  N = 7 N = 18 N = 7 N = 18 N = 47 N = 16
  N (%) N (%) N (%) N (%) N (%) N (%)
Lithium 4 (57.1) 11 (61.1) 5 (71.4) 3 (16.7) 8 (17.0) 4 (25.0)
Anticonvulsants 2 (28.6) 5 (27.8) 3 (42.9) 7 (38.9) 25 (53.2) 4 (25.0)
Antidepressants 3 (42.9) 13 (72.2) 1 (14.3) 10 (55.6) 34 (72.3) 10 (62.5)
Neuroleptics 3 (42.9) 11 (61.1) 4 (57.1) 7 (38.9) 20 (42.6) 6 (37.5)
First generation 0 1 (5.6) 1 (14.3) 1 (5.6) 3 (6.4) 0
Second generation 3 (42.9) 11 (61.1) 3 (42.9) 6 (33.3) 18 (38.3) 6 (37.5)
Benzodiazepines 0 7 (38.9) 3 (42.9) 3 (16.7) 8 (17.0) 5 (31.3)
At least one MS or AAP in therapeutic range* 7 (100) 15 (83.3) 5 (71) 8 (44.4) 26 (55.3) 6 (37.5)
At least one psychotropic drug 7 (100) 18 (100) 7 (100) 16 (88.9) 44 (93.6) 13 (81.3)
  1. *MS or AAP in therapeutic range: lithium serum levels ≥0.5 mEq/L; valproate ≥750 mg daily; carbamazepine ≥600 mg daily; lamotrigine ≥50 mg daily; olanzapine ≥5 mg daily; risperidone ≥2 mg daily; quetiapine ≥150 mg daily.